
Droxicainide
CAS No. 78289-26-6
Droxicainide( —— )
Catalog No. M26178 CAS No. 78289-26-6
Droxicainide is an antiarrhythmic agent.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 448 | Get Quote |
![]() ![]() |
10MG | 653 | Get Quote |
![]() ![]() |
25MG | 1017 | Get Quote |
![]() ![]() |
50MG | 1368 | Get Quote |
![]() ![]() |
100MG | 1782 | Get Quote |
![]() ![]() |
500MG | 3573 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameDroxicainide
-
NoteResearch use only, not for human use.
-
Brief DescriptionDroxicainide is an antiarrhythmic agent.
-
DescriptionDroxicainide is an antiarrhythmic agent.(In Vivo):In coronary artery occlusion studies, Droxicainide reduced the progression of hypoperfusion to necrosis and reduced the infarct size in dogs.Droxicainide reduces ansa node, atrioventricular excitability and contractility, and increases intractable studies on spontaneous beating atrium, electrical stimulation atrium and isolated papillary muscles in rats.
-
In Vitro——
-
In VivoIn coronary artery occlusion study, Droxicainide reduces hypoperfused area that evolves to necrosis, and reduces the infarct size in dogs. Droxicainide decreases the sinus node, atrial and ventricular excitability and contractile force and increases the refractoriness in the study of spontaneously beating atria, electrically stimulated atria and papillary muscles isolated from rats.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorER
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number78289-26-6
-
Formula Weight276.38
-
Molecular FormulaC16H24N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1cccc(C)c1NC(=O)C1CCCCN1CCO
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ohta, K., et al. Promising core structure for nuclear receptor ligands:Design and synthesis of novel estrogen receptor ligands based on diphenylamine skeleton. Bioorganic & Medicinal Chemistry Letters.2008;18(18), 5050–5053.
molnova catalog



related products
-
Trimethoxystilbene
3, 5, 4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast Y cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
-
Tetramethylammonium
Tetramethylammonium ion has limited toxicity of dermal exposure, but fatal effects can be introduced by pre-treatment with hydroxide ion.
-
Dihydrosamidin
Dihydrosamidin is a natural product. It inhibiting effect on triacylglycerol accumulation in 3T3-L1 preadipocytes.